Adenosine A 2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasiaBIOMEDICINE & PHARMACOTHERAPYIF7.52024-04-015OAAI
Mechanosensitive ACKR4 scavenges CCR7 chemokines to facilitate T cell de-adhesion and passive transport by flow in inflamed afferent lymphaticsCELL REPORTSIF6.92022-02-0118OAAI
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine3-羟基-l-犬尿胺是一种免疫调节生物胺NATURE COMMUNICATIONSIF15.72021-07-2132OAAI
Structure and Immune Function of Afferent Lymphatics and Their Mechanistic Contribution to Dendritic Cell and T Cell TraffickingCELLSIF5.22021-05-2028OAAI
Upregulation of VCAM-1 in lymphatic collectors supports dendritic cell entry and rapid migration to lymph nodes in inflammationJOURNAL OF EXPERIMENTAL MEDICINEIF10.62021-05-1439OAAI
Dual-Activatable Cell Tracker for Controlled and Prolonged Single-Cell LabelingACS CHEMICAL BIOLOGYIF3.82020-04-1614OAAI
Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of MacrophagesFRONTIERS IN IMMUNOLOGYIF5.92019-03-2027OAAI
Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic EpidermisJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-01-0131OAAI
Decreased SAPK/JNK signalling affects cytokine release and STAT3 activation in psoriatic fibroblastsEXPERIMENTAL DERMATOLOGYIF3.12015-08-218OAAI
Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in miceEXPERIMENTAL DERMATOLOGYIF3.12014-07-2122PREAI